Publication | Closed Access
Contralateral Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
616
Citations
12
References
2004
Year
The risk of contralateral breast cancer in women with a BRCA mutation is approximately 40% at 10 years, and is reduced in women who take tamoxifen or who undergo an oophorectomy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1